Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $3.06 Analyst target: $30.00 Upside: 880.39%
Immutep Limited, a biotechnology company, is dedicated to the research and development of pharmaceutical candidates. The company is headquartered in Sydney, Australia.
See the full interactive analysis & chart →Informational only — not investment advice.